Worldwide access to treatment for end-stage kidney disease: a systematic review

13 March 2015

Thaminda Liyanage, MBBS†, Toshiharu Ninomiya, PhD†, Prof Vivekanand Jha, DM, Prof Bruce Neal, PhD, Halle Marie Patrice, MD, Ikechi Okpechi, PhD, Prof Ming-hui Zhao, PhD, Jicheng Lv, PhD, Prof Amit X Garg, PhD, John Knight, MBA, Prof Anthony Rodgers, PhD, Martin Gallagher, PhD, Sradha Kotwal, MD, Prof Alan Cass, PhD, Prof Vlado Perkovic, PhD DOI:


End-stage kidney disease is a leading cause of morbidity and mortality worldwide. Prevalence of the disease and worldwide use of renal replacement therapy (RRT) are expected to rise sharply in the next decade. The authors aimed to quantify estimates of this burden.